肺栓塞后慢性血栓栓塞性肺动脉高压与功能损害:FOCUS研究
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
为系统评估急性肺栓塞(PE)的远期结局,并探讨符合前瞻性定义标准的肺栓塞后损伤(PPEI)的临床意义,在德国17家高容量中心开展了一项前瞻性多中心观察性队列研究。连续纳入确诊为急性症状性PE的成年患者,采用标准化评估方案,并在3、12和24个月时进行预定访视。共同主要结局为:(i)慢性血栓栓塞性肺动脉高压(CTEPH)的诊断;(ii)PPEI,即随访期间持续性或恶化的临床、功能、生化和影像学参数的综合。共有1017例患者(45%为女性,中位年龄64岁)纳入主要分析。PE诊断后中位随访时间为732天。16例(1.6%)患者诊断为CTEPH,中位诊断时间为129天;估计2年累积发生率为2.3%(1.2-4.4%)。共有880例患者可评估PPEI;2年累积发生率为16.0%(95%置信区间12.8-20.8%)。PPEI有助于识别随访期间诊断为CTEPH的16例患者中的15例(CTEPH与无CTEPH的风险比为393;95%置信区间73-2119)。与无PPEI的患者相比,PPEI患者再住院和死亡风险更高,生活质量更差。在这项前瞻性研究中,CTEPH的2年累积发生率为2.3%,但通过标准化标准诊断的PPEI较为常见。我们的发现支持对急性PE后患者进行系统随访,并可能有助于优化指南推荐和PE后管理算法。
To systematically assess late outcomes of acute pulmonary embolism (PE) and to investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively defined criteria. A prospective multicentre observational cohort study was conducted in 17 large-volume centres across Germany. Adult consecutive patients with confirmed acute symptomatic PE were followed with a standardized assessment plan and pre-defined visits at 3, 12, and 24 months. The co-primary outcomes were (i) diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH), and (ii) PPEI, a combination of persistent or worsening clinical, functional, biochemical, and imaging parameters during follow-up. A total of 1017 patients (45% women, median age 64 years) were included in the primary analysis. They were followed for a median duration of 732 days after PE diagnosis. The CTEPH was diagnosed in 16 (1.6%) patients, after a median of 129 days; the estimated 2-year cumulative incidence was 2.3% (1.2-4.4%). Overall, 880 patients were evaluable for PPEI; the 2-year cumulative incidence was 16.0% (95% confidence interval 12.8-20.8%). The PPEI helped to identify 15 of the 16 patients diagnosed with CTEPH during follow-up (hazard ratio for CTEPH vs. no CTEPH 393; 95% confidence interval 73-2119). Patients with PPEI had a higher risk of re-hospitalization and death as well as worse quality of life compared with those without PPEI. In this prospective study, the cumulative 2-year incidence of CTEPH was 2.3%, but PPEI diagnosed by standardized criteria was frequent. Our findings support systematic follow-up of patients after acute PE and may help to optimize guideline recommendations and algorithms for post-PE care.
Luca Valerio, Anna C Mavromanoli, Stefano Barco, Christina Abele, Dorothea Becker, Leonhard Bruch, et al. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.. European heart journal. 2022; doi:10.1093/eurheartj/ehac206.
Luca Valerio, Anna C Mavromanoli, Stefano Barco, Christina Abele, Dorothea Becker, Leonhard Bruch, et al (2022). Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.. European heart journal. https://doi.org/10.1093/eurheartj/ehac206
Luca Valerio, Anna C Mavromanoli, Stefano Barco, Christina Abele, Dorothea Becker, Leonhard Bruch, et al. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.[J]. European heart journal, 2022 doi:10.1093/eurheartj/ehac206.
翻译全文 · AI 文献问答 · PDF 原文下载 · 引用导出